Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 129-137

  Leiter, Ulrike ^a   Buettner, Petra G ^b   Bohnenberger, Katrin ^a   Eigentler, Thomas ^a   Meier, Friedegund ^a   Moehrle, Matthias ^a   Breuninger, Helmut ^a   Garbe, Claus ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EVENT FREE SURVIVAL; FEMALE; GERMANY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY CUTANEOUS MELANOMA; PRIMARY TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; SCHOOL CHILD; SENTINEL LYMPH NODE DISSECTION; SURGICAL RISK; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 74649084154     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0780-2     Document Type: Article

References (36)

1. CM Balch SJ Soong MB Atkins AC Buzaid N Cascinelli DG Coit, et al. 2004 An evidence-based staging system for cutaneous melanoma CA Cancer J Clin 54 3 131 149 10.3322/canjclin.54.3.131 15195788
2. N Cascinelli F Belli M Santinami V Fait A Testori W Ruka, et al. 2000 Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience Ann Surg Oncol 7 6 469 474 10.1007/s10434-000-0469-z 1:STN:280:DC%2BD3M%2FlsFClsw%3D%3D 10894144 (Pubitemid 30439307)
3. DL Morton L Wanek JA Nizze RM Elashoff JH Wong 1991 Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic Ann Surg Oncol 214 4 491 499 1:STN:280:DyaK38%2FmtFamsg%3D%3D
4. JE Gershenwald W Thompson PF Mansfield JE Lee MI Colome CH Tseng, et al. 1999 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 3 976 983 1:STN:280:DyaK1M7mvVymsg%3D%3D 10071292
5. S Kettlewell C Moyes C Bray D Soutar A MacKay D Byrne, et al. 2006 Value of sentinel node status as a prognostic factor in melanoma: prospective observational study BMJ 332 7555 1423 10.1136/bmj.38849.680509.AE 16735303 (Pubitemid 44365321)
6. VS Yee JF Thompson JG McKinnon RA Scolyer LX Li WH McCarthy, et al. 2005 Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy Ann Surg Oncol 12 6 429 439 10.1245/ASO.2005.03.074 15886905 (Pubitemid 40884257)
7. CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit, et al. 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 16 3635 3648 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
8. DL Morton JF Thompson AJ Cochran N Mozzillo R Elashoff R Essner, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 13 1307 1317 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D 17005948 (Pubitemid 44465459)
9. DL Morton DS Hoon AJ Cochran RR Turner R Essner H Takeuchi, et al. 2003 Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann Surg Oncol 238 4 538 549
10. N Medalie AB Ackerman 2004 Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now Br J Dermatol 151 2 298 307 10.1111/j.1365-2133.2004.06132.x 1:STN:280:DC%2BD2cvit1Shsw%3D%3D 15327536 (Pubitemid 39215143)
11. F Meier S Will U Ellwanger B Schlagenhauff B Schittek G Rassner, et al. 2002 Metastatic pathways and time courses in the orderly progression of cutaneous melanoma Br J Dermatol 147 1 62 70 10.1046/j.1365-2133.2002.04867.x 1:STN:280:DC%2BD38zls1Kkuw%3D%3D 12100186 (Pubitemid 34779439)
12. DL Morton AJ Cochran JF Thompson R Elashoff R Essner EC Glass, et al. 2005 Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial Ann Surg Oncol 242 3 302 311
13. DL Morton AJ Cochran JF Thompson 2008 The rationale for sentinel-node biopsy in primary melanoma Nat Clin Pract Oncol 5 9 510 511 10.1038/ncponc1205 18679393
14. AJ Cochran DL Morton 2006 Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes Am J Surg Pathol 30 3 419 420 16538068
15. AJ Cochran RR Huang J Lee E Itakura SP Leong R Essner 2006 Tumour-induced immune modulation of sentinel lymph nodes Nat Rev Immunol 6 9 659 670 10.1038/nri1919 1:CAS:528:DC%2BD28Xos12gt7w%3D 16932751 (Pubitemid 44298215)
16. CM Balch N Cascinelli 2006 Sentinel-node biopsy in melanoma N Engl J Med 355 13 1370 1371 10.1056/NEJMe068147 1:CAS:528:DC%2BD2sXisVGitLw%3D 17005955 (Pubitemid 44465466)
17. MI Ross JE Gershenwald 2008 How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)? Ann Surg Oncol 15 3 670 673 10.1245/s10434-008-9828-y 18228101
18. JM Thomas 2008 Prognostic false-positivity of the sentinel node in melanoma Nat Clin Pract Oncol 5 1 18 23 10.1038/ncponc1014 18097453
19. JD Wagner MS Gordon TY Chuang JJ Coleman III 2000 Current therapy of cutaneous melanoma Plast Reconstr Surg 105 5 1774 1799 10.1097/00006534- 200004050-00028 1:STN:280:DC%2BD3c3mslWisg%3D%3D 10809113
20. HJ Blaheta U Ellwanger B Schittek K Sotlar E MacZey H Breuninger, et al. 2000 Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma J Invest Dermatol 114 4 637 642 10.1046/j.1523-1747.2000.00925.x 1:CAS:528: DC%2BD3cXisFKktrk%3D 10733666 (Pubitemid 30226993)
21. C Garbe A Paul H Kohler-Spath U Ellwanger W Stroebel M Schwarz, et al. 2003 Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 3 520 529 10.1200/JCO.2003.01.091 12560444 (Pubitemid 46606483)
22. CM Balch SJ Soong JE Gershenwald JF Thompson DS Reintgen N Cascinelli, et al. 2001 Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 16 3622 3634 1:STN:280:DC%2BD3MvlvV2ktA%3D%3D 11504744
23. N Cascinelli A Morabito M Santinami RM MacKie F Belli 1998 Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme Lancet 351 9105 793 796 10.1016/S0140-6736(97)08260-3 1:STN:280:DyaK1c7nvVOksQ%3D%3D 9519951 (Pubitemid 28112341)
24. L Kretschmer R Hilgers M Mohrle BR Balda H Breuninger B Konz, et al. 2004 Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease Eur J Cancer 40 2 212 218 10.1016/j.ejca.2003.07.003 1:STN:280:DC%2BD2c%2FivFensQ%3D%3D 14728935 (Pubitemid 38077023)
25. A Arens J Osinga V Schwipper O Schober H Tilkorn J Liebau 2003 Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards Chirurg 74 7 665 670 10.1007/s00104-003-0659-x 1:STN:280:DC%2BD3szltVGltg%3D%3D 12883795 (Pubitemid 38264799)
26. A Blum B Schlagenhauff W Stroebel H Breuninger G Rassner C Garbe 2000 Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients Cancer 88 11 2534 2539 10.1002/1097-0142(20000601)88:11<2534::AID-CNCR15>3.0.CO;2-2 1:STN:280:DC%2BD3cvisFyrsg%3D%3D 10861430 (Pubitemid 30331960)
27. DR Berk DL Johnson A Uzieblo M Kiernan SM Swetter 2005 Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004 Arch Dermatol 141 8 1016 1022 10.1001/archderm.141.8.1016 16103331 (Pubitemid 46165525)
28. N Cascinelli E Bombardieri R Bufalino T Camerini A Carbone C Clemente, et al. 2006 Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival J Clin Oncol 24 27 4464 4471 10.1200/JCO.2006.06.3198 16983115 (Pubitemid 46630985)
29. E Cuchet N Pinel D Corcella JP Vuillez J Lebeau F Moutet, et al. 2007 Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up Eur J Dermatol 17 5 387 391 17673381
30. S Debarbieux G Duru S Dalle O Beatrix B Balme L Thomas 2007 Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection Br J Dermatol 157 1 58 67 10.1111/j.1365-2133.2007.07937.x 1:STN:280:DC%2BD2szmtlKlsw%3D%3D 17501957 (Pubitemid 46934258)
31. JB Roaten N Pearlman R Gonzalez R Gonzalez MD McCarter 2005 Identifying risk factors for complications following sentinel lymph node biopsy for melanoma Arch Surg 140 1 85 89 10.1001/archsurg.140.1.85 15655211 (Pubitemid 40105067)
32. N Wasserberg H Tulchinsky J Schachter M Feinmesser H Gutman 2004 Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free Eur J Surg Oncol 30 8 851 856 10.1016/j.ejso.2004.06.021 1:STN:280: DC%2BD2cvjtFaksg%3D%3D 15336731 (Pubitemid 39186072)
33. JM Thomas MA Clark 2004 Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma Eur J Surg Oncol 30 6 686 691 10.1016/j.ejso.2004.04.004 1:STN:280:DC%2BD2czltleltA%3D%3D 15256245 (Pubitemid 39060740)
34. JC Kang LA Wanek R Essner MB Faries LJ Foshag DL Morton 2005 Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma J Clin Oncol 23 21 4764 4770 10.1200/JCO.2005.20.537 16034052 (Pubitemid 46224080)
35. L Kretschmer I Beckmann KM Thoms H Haenssle HP Bertsch C Neumann 2005 Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas Eur J Cancer 41 4 531 538 10.1016/j.ejca.2004. 11.019 1:STN:280:DC%2BD2M7gslCnuw%3D%3D 15737557 (Pubitemid 40297895)
36. TM Pawlik MI Ross JF Thompson AM Eggermont JE Gershenwald 2005 The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes J Clin Oncol 23 21 4588 4590 10.1200/JCO.2005.12.245 16034040 (Pubitemid 46224060)